Cardiac involvement in scleroderma

Cardiac involvement in systemic sclerosis can be manifested as myocardial disease, pericardial disease, conduction system disease, or arrhythmias. Clinical cardiac involvement in scleroderma is a harbinger of adverse prognosis. Cardiac abnormalities in both asymptomatic and symptomatic patients and their possible etiologies are discussed in this article. Treatment options are also reviewed. though at the present time the treatment of cardiac scleroderma is essentially symptomatic and empiric with the benefit of immunosuppressive and vasodilation therapy being uncertain.